Medical/Pharmaceuticals

AsiaMedic Sets New Standard in Healthcare with Installation of First SIGNA™ Hero 3.0T MRI Scanner in Asia-Pacific

SINGAPORE, Aug. 25, 2023 /PRNewswire/ -- AsiaMedic , a leading health screening and diagnostic imaging specialist, has taken a groundbreaking leap in healthcare innovation with the installation of the first-ever SIGNA™ Hero 3.0T magnetic resonance imaging (MRI) sca...

2023-08-25 14:12 3566

3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced

HONG KONG, Aug. 25, 2023 /PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today released its 2023 interim results. Revenue in the first half of 2023 reached approximatelyRMB3,783.8 million, up 22.3% on a yearly basis. Gross profit was approximatelyRMB3,201.6 million, up ...

2023-08-25 10:06 6734

Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy

SHANGHAI, Aug. 25, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Ph...

2023-08-25 08:15 4076

Antheia Achieves Major Commercial Milestone

Company's first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMs and APIs MENLO PARK, Calif., Aug. 25, 2023 /PRNewswire/ -- Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today announced the...

2023-08-25 08:01 3388

YS Biopharma Announces Purchase of Shares by Company Officers

GAITHERSBURG, Md., Aug. 25, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2023-08-25 04:15 3135

Ping An Health announces 2023 interim results

Managed care business delivers robust performance  Market leadership in corporate health management drives loss narrowing by 47.2% HONG KONG and SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or "Ping An Health", Stock Code: 1833.H...

2023-08-24 20:58 10285

Vittra APS Unique composite by FGM is appointed as a solution to a clinical problem by the renowned agency Dental Advisor

JOINVILLE, Brazil, Aug. 24, 2023 /PRNewswire/ -- The Vittra APS Unique composite, by FGM Dental Group, was recognized for its chameleon effect in the publication Clinical Problem Solvers of the renowned American agency Dental Advisor - a global reference in the field of dentistry. In the publicat...

2023-08-24 18:00 2310

MRI Software's first 'Voice of the Strata Manager' report reveals unseen pressures of high-demand real estate industry job

Despite dealing with difficult behaviour from owners and 50+ hour work weeks, strata managers are optimistic about the future of their jobs and industry SYDNEY, Aug. 24, 2023 /PRNewswire/ -- A new national 'Voice of the Strata Manager' report reveals an alarming number of Australian strata manage...

2023-08-24 13:02 3444

Everest Medicines Announces Interim Results for First Half of 2023

SHANGHAI, Aug. 24, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2023, ...

2023-08-24 08:15 8082

Salvia BioElectronics: First-Ever Patient Treated with Breakthrough Neuromodulation Solution for Severe Migraine and Cluster Headache in Australia

NAMBOUR, Australia, Aug. 24, 2023 /PRNewswire/ -- In a remarkable medical milestone, an Australian patient at Nambour Selangor Private Hospital became the first-ever patient to receive Salvia BioElectronics' paper-thin neuromodulation solution for severe migraine and cluster headache. This groun...

2023-08-24 05:45 2258

Optum Applauded by Frost & Sullivan for Advancing the Use of Real-World Evidence by Life Sciences Companies and for Its Market-leading Position

With a legacy of industry leadership, Optum offers a compelling value proposition and innovative solutions that effectively address market gaps, underpinning its sustained success. SAN ANTONIO, Aug. 23, 2023 /PRNewswire/ -- Frost & Sullivan recently assessed the landscape for real-world evidence...

2023-08-23 22:00 2685

Crystal S. Denlinger, MD, FACP, Named New CEO of National Comprehensive Cancer Network; Robert W. Carlson, MD, Retiring After 10+ Years Leading Global Oncology Nonprofit

Dr. Denlinger is currently NCCN's Chief Scientific Officer and previously served as Chair and Member of multiple NCCN Guidelines Panels—in charge of maintaining gold-standard evidence-based expert consensus cancer treatment recommendations. PLYMOUTH MEETING, Pa., Aug. 23, 2023 /PRNewswire/ -- To...

2023-08-23 20:06 3082

Innovent Announces 2023 Interim Results and Business Updates

Remarkable achievements with accelerated growth and improved efficiency to underpin sustainable growth ROCKVILLE, M.D. and SUZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and comme...

2023-08-23 19:38 6487

Trisol announces successful implants of its Transcatheter Tricuspid Valve in the US

Two implants were successfully conducted as part of the FDA approved Early Feasibility Study inthe United States YOKNEAM, Israel, Aug. 23, 2023 /PRNewswire/ -- The heart teams at the Piedmont Heart Institute inAtlanta, Georgia, USA and the University of Virginia Health System inCharlottesville, ...

2023-08-23 18:07 1724

Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company

MELBOURNE, Australia, Aug. 23, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended30 June 2023. All figures are in AUD$ unless otherwise stated.[1] Financial highlights * Total Group revenue $220.8M ...

2023-08-23 17:40 2410

USANA Philippines Celebrates Legacy of Wellness Empowerment With Enterprise Asia Linchpin of Asia Awards 2023

SINGAPORE, Aug. 22, 2023 /PRNewswire/ -- Founded in 1992 by microbiologist and immunologist Dr. Myron Wentz, USANA Health Sciences is a U.S.-based international direct-selling company that researches, manufactures, and sells premium, science-based supplements, personal care, and healthy living...

2023-08-23 17:06 2633

Leading by Inspiration: KPJ Tawakkal KL Specialist Hospital Triumphs with Asia Pacific Enterprise Award for its Exceptional Brand

SINGAPORE, Aug. 23, 2023 /PRNewswire/ -- KPJ Tawakkal KL Specialist Hospital (KPJ TWKL), a renowned name in the healthcare industry, has achieved yet another milestone by being honored with the prestigious Inspirational Brand Award at the Asia Pacific Enterprise Awards 2023 Malaysia. This recogni...

2023-08-23 15:18 2592

MGI Partners with NGeneBio to Advance Precision Medicine

SEOUL, South Korea, Aug. 23, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science and NGeneBio, a company specializing in next-generation sequencing-based diagnostic have signed a memorandum of understanding (MOU) to expand the commercial access...

2023-08-23 09:00 3275

Lynk Pharmaceuticals Announces Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Ankylosing Spondylitis

HANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (referred to as "Lynk Pharmaceuticals"), an innovative clinical stage company, announced positive topline data from a Phase II clinical trial of LNK01001 for the treatment of ankylosing spondylitis (AS). The study, led...

2023-08-23 08:00 5060

Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results

First patient dosed in a PEG-IFN-α controlled BRII-835 + PEG-IFN-α combination Phase 2 study for HBV functional cure First of several studies to investigate the potential of BRII-179 in enriching patients with strong intrinsic anti-HBsAg responses for curative treatments to start before the end ...

2023-08-22 22:00 5390
1 ... 225226227228229230231 ... 381

Week's Top Stories